EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Risk of Disease Progression of Type 1 Diabetes in First‐Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China

Das Risiko des Fortschreitens von Typ-1-Diabetes bei erstgradigen Verwandten von Menschen mit Typ-1-Diabetes: Design und Begründung einer prospektiven Längsschnittstudie in China

Lixin Guo iD, Xiaoping Luo, Yan Bi iD, Bingyan Cao, Guanping Dong, Sheng Jiang, Guijun Qin iD, Hong Qiao, Zhongyan Shan, Tao Yang iD, Gaohui Zhu, Min Li und 3 weitere

Diabetes, Obesity and Metabolism · 2026-06 · 28 (6) · 4610-4618

DOI: 10.1111/dom.70706 ↗

Auf einen Blick

Die Studie untersucht bei erstgradigen Verwandten von Menschen mit Typ-1-Diabetes in China das Fortschreiten zu Stadium-3-T1D. Geplant ist die Beobachtung IAb-positiver Personen über bis zu 5 Jahre.

Fragestellung

Wie hoch ist das Risiko für ein Fortschreiten zu Stadium-3-T1D bei erstgradigen Verwandten von Menschen mit Typ-1-Diabetes in China?

Methode

Prospektive Längsschnittstudie an etwa 50 Krankenhäusern in China; Screening auf IAb im Blut; IAb-positive Personen werden bis zu 5 Jahre weiter untersucht.

Ergebnisse

Das Protokoll beschreibt die geplante Rekrutierung von 5500 Teilnehmenden. Ergebnisse liegen in dem Abstract noch nicht vor.

Einschränkungen

Keine Ergebnisse berichtet; es handelt sich um Design und Begründung der Studie.

Schlussfolgerung der Autor:innen

Durch frühes Screening und Monitoring soll ein umfassendes Verständnis der T1D-Progression in der chinesischen Bevölkerung entstehen.

Kernaussagen

  • Erstgradige Verwandte von T1D-Patient:innen werden auf IAb gescreent.
  • IAb-positive Personen werden bis zu 5 Jahre nachbeobachtet.
  • Geplante Rekrutierung: 5500 Teilnehmende.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 30.03.2026. Verfasst von Lixin Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, …. Hauptthemen laut MEDLINE: Autoantibodies, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi China Investment Company.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In China, information on individuals who test positive for islet autoantibodies (IAb), including single IAb‐positive individuals and those with early‐stage Type 1 diabetes (T1D), and their risk of progression to Stage 3 T1D is limited. The goal of this study is to assess the risk of progression to T1D in first‐degree relatives (FDRs) of people with T1D in China. Materials and Methods This prospective, longitudinal study, being conducted at approximately 50 hospitals in China, will screen FDRs of individuals with T1D to identify those at risk for developing the disease by testing for the presence of IAb in the blood. IAb‐positive individuals will undergo further testing for up to 5 years, with the primary objective of assessing their risk of Stage 3 T1D onset. During the monitoring period, participants with single IAb‐positivity will be tested for glycated haemoglobin (HbA1c) and IAb every year; those with multiple IAb‐positivity will have an HbA1c and oral glucose tolerance test (OGTT) every year (Stage 1 T1D), or OGTT or random blood glucose test in alternate 6‐monthly intervals and HbA1c every 3 months (Stage 2 T1D). Participants who develop Stage 3 T1D during monitoring can undergo extended follow‐up to assess changes in β‐cell function, glycaemic outcomes and IAb status during the first 12 months after diagnosis. The study plans to enrol 5500 participants; enrolment is ongoing.

Conclusions

Through early screening and monitoring of disease progression in FDRs of T1D probands, this study will provide a comprehensive understanding of T1D progression in the Chinese population. Trial Registration: Chinese Clinical Trial Registry identifier: ChiCTR2600119032

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesDiabetes Mellitus, Type 1AdolescentAdultChildFemaleHumansMaleChinaDisease ProgressionFamilyGenetic Predisposition to DiseaseGlucose Tolerance TestGlycated HemoglobinIslets of LangerhansLongitudinal StudiesProspective StudiesRisk FactorsObservational Studies as TopicMulticenter Studies as Topic

Stichwörter der Autor:innen

autoimmunitydisease preventionfirst‐degree relativespancreatic autoantibodiesrisk predictiontype 1 diabetes

Substanzen

AutoantibodiesGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
  • Department of Endocrinology, Capital Center for Children's Health, Capital Medical University, Beijing, China.
  • Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Department of Endocrinology, the First Affiliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China.

ORCID-Profile: Lixin Guo, Yan Bi, Guijun Qin, Tao Yang

Förderung

  • Sanofi China Investment Company

Zitieren

APA

Guo, L., Luo, X., Bi, Y., Cao, B., Dong, G., Jiang, S., Qin, G., Qiao, H., Shan, Z., Yang, T., Zhu, G., Li, M., Tang, S., Zhang, M., & Li, W. (2026). The Risk of Disease Progression of Type 1 Diabetes in First‐Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China. Diabetes, Obesity and Metabolism, 28(6), 4610-4618. https://doi.org/10.1111/dom.70706

Vancouver

Guo L, Luo X, Bi Y, Cao B, Dong G, Jiang S, et al. The Risk of Disease Progression of Type 1 Diabetes in First‐Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China. Diabetes, Obesity and Metabolism. 2026;28(6):4610-4618. doi:10.1111/dom.70706

BibTeX
@article{Guo2026,
  author = {Guo, Lixin and Luo, Xiaoping and Bi, Yan and Cao, Bingyan and Dong, Guanping and Jiang, Sheng and Qin, Guijun and Qiao, Hong and Shan, Zhongyan and Yang, Tao and Zhu, Gaohui and Li, Min and Tang, Sunyinyan and Zhang, Minlu and Li, Wenjuan},
  title = {The Risk of Disease Progression of Type 1 Diabetes in First‐Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {6},
  pages = {4610--4618},
  doi = {10.1111/dom.70706}
}
Kostenlos starten →